Since two-thirds of breast cancer patients demonstrate GRP78 upregulation, research suggests that in this subset of breast cancers, the increased expression of GRP78 will block the pro-apoptotic functions of Bik, thus inhibiting cell death mediated by anti-estrogen deprivation [96]. Here, HSPA5 is linked to breast carcinoma.